Ripple Therapeutics announced today that it entered into a deal with a Bausch + Lomb affiliate related to drug delivery ...
Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...
PreEvnt aims for Isaac to help people with type 1, type 2 and pre-diabetes, reducing the need for or frequency of ...
Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...
The G7 15 Day CGM in use. [Image courtesy of Dexcom] Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next month. The San ...
The Smart Basal offering with the G7 CGM. [Images courtesy of Dexcom] Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer. The ...
[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance. Modular Medical’s current pump, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback